HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,749-2,760 of 4,505
Drug study icon
TerminatedNCT00658645

Efficacy of Bifeprunox in people with Schizophrenia

What is this study about?

Researchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.

This study ended early.

Multiple locations, including Radnevo
SchizophreniaMedication studyAges 18–65
Countries
Bulgaria, China, Greece, + 5 others
Sponsor
H. Lundbeck A/S
Behavioral study icon
CompletedNCT03891186

Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol

Official study title

A Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol

This study has finished and is no longer accepting participants.

In Portalegre
SchizophreniaBehavioural studyAges 18–65
Countries
Portugal
Sponsor
University Rovira i Virgili
Behavioral study icon
CompletedNCT01279070

Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia

Official study title

Efficacy of Repyflec Cognitive Remediation Group Training in Cognition, Functional Outcomes and Psychiatric Symptoms of Outpatients With Schizophrenia.

This study has finished and is no longer accepting participants.

In Sant Boi de Llobregat
SchizophreniaBehavioural studyAges 18–60
Countries
Spain
Sponsor
Fundació Sant Joan de Déu
Drug study icon
CompletedNCT01393613

Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia

What is this study about?

Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–65
Countries
United States, Colombia, Croatia, + 5 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT02477670

Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01668797

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 18–65
Countries
United States, Colombia, Malaysia, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.